Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study.
about
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patientsAngiotensin converting enzyme inhibitors and angiotensin II receptor blockers for preserving residual kidney function in peritoneal dialysis patientsPharmacologic management of chronic reno-cardiac syndromeEffect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trialsRenin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort studyEducating end-stage renal disease patients on dialysis modality selection.Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.Is hypoalbuminemia a prognostic risk factor for contrast-induced nephropathy in peritoneal dialysis patients?Hemodialysis: core curriculum 2014.Decline in residual renal function in automated compared with continuous ambulatory peritoneal dialysis.Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review.In Peritoneal Dialysis, Is There Sufficient Evidence to Make "PD First" Therapy?Peritoneal Dialysis Drop-out: Causes and Prevention StrategiesPredictors of residual renal function decline in patients undergoing continuous ambulatory peritoneal dialysisLeft ventricular dysfunction in the haemodialysis population.Metabolic syndrome in peritoneal dialysis patients.Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making.Relationship between CRP polymorphism and cardiovascular events in Chinese peritoneal dialysis patientsISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors.Improving outcomes in CKD and ESRD patients: carrying the torch from training to practice.The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients.The Association of Losartan and Ramipril Therapy With Kidney and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: A Chinese Nation-Wide Cohort Study in Taiwan.Residual renal function and dialysis modality: is it really beneficial to preserve residual renal function in dialysis patients?Is it time to revisit residual renal function in haemodialysis?Long-term outcome of chronic dialysis in children.The prescription of peritoneal dialysis.Peritoneal membrane structural and functional changes during peritoneal dialysis.Management of ischemic heart disease in patients with chronic kidney disease.Serum potassium levels and its variability in incident peritoneal dialysis patients: associations with mortalityThe importance of residual renal function in chronic dialysed patients.Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease.Cardiovascular complications in diabetic kidney disease.Should all hypertensive dialysis patients receive a blocker of the Renin-Angiotensin system?Can we reduce the cardiovascular risk in peritoneal dialysis patients?Atherosclerosis in chronic kidney disease: the role of macrophagesTargeting the renin angiotensin system in dialysis patients.The estimation, measurement, and relevance of the glomerular filtration rate in stage 5 chronic kidney disease.Strategies for the preservation of residual renal function in pediatric dialysis patients.Preserving residual renal function in dialysis: what we know.Evaluating the benefits of home-based peritoneal dialysis.
P2860
Q24193825-5A6DE48F-ED71-4AB4-808D-31D9490DDA8DQ24234831-4AD2FAE6-3DCE-4BBB-80EF-2E450320244CQ26829812-5C4A5DAB-C8F1-4C9A-8067-E8B38424DC08Q33413288-27F7A7E9-8AA9-492C-8010-3C0CF393D40CQ33808339-78290EF7-0185-44AE-BB09-EEF9200C333AQ33816963-F56949E7-E746-437A-BBEF-A3A9CE62DA42Q33859007-AB0A7171-5155-42B6-B2E0-5A8B02F45778Q34351241-3B40E79B-1099-439D-A7C0-3E7B5B669E7EQ34770756-029FC3C8-42B0-48B0-8C77-CCEBFE8E41CEQ34857717-338B0EBB-1AA4-4622-8FF7-292C54EAFE49Q34989922-3E4ECB12-5768-470F-821E-385FD92B0558Q35113627-97BF070E-516F-4785-89E7-E26FA6C4AF0DQ35496077-1673C27A-7841-4C3B-8881-E031953CBBBBQ35524742-A4ED65F3-B869-40BB-A54A-001332084ABCQ35573726-15164BB8-3940-4371-8F3F-486201290A12Q35573741-1785CAFD-FA35-40AE-BDE0-46B5094A02C1Q35574112-07212235-BDCE-4E0E-84A7-9D585B8AC78CQ35758519-3B10D016-E419-4CB8-B1DC-F380EE8660C1Q35904398-CC135EAF-0AB4-4CCA-8F79-12EB554746F3Q35907180-6FB70896-7D78-4422-AE1D-04DDE24EBABAQ36157105-15147462-B5C1-4DA8-ACE9-087781845266Q36359042-56001EC1-950F-4721-AE75-456E212714BFQ36556709-271C0FCB-9551-46BA-A322-CF0870FF0C11Q36820013-B58EEFE3-EA8D-436B-AAF7-A7662B3376F0Q37063372-ACEA5AD1-BA83-4BF7-A03C-B78D8C7D0138Q37076491-A56A370A-28B0-4E10-85A0-F6D0F64A798EQ37117983-63541742-7D56-4131-BC2C-99F50B9A57D8Q37239030-DDAA6A5A-1478-45DF-AE32-0D85CAD93BCEQ37520876-BEA27BB3-95FE-4FD1-BAFC-9E1AA01C11F3Q37682811-53408A0D-CF6B-4F4C-AB63-4B932C8859A9Q37702722-98E5A45D-B443-4472-974F-23FBA643F94BQ37704589-88AA32A0-B94B-4707-AB2D-310E69339EFFQ37785841-1563E240-D5B3-4D9E-8A71-7F273ECBD143Q37787773-770B222D-5100-40EF-A13F-B28F78864DD6Q37811885-C38BF75E-337E-47C1-9D78-AE7E6C27B13EQ37891151-A8B000AD-85B6-47CD-8840-150431E3CF38Q37932044-B78CD23B-9FB5-4ECA-A618-A948D3104671Q38122625-A7C0A4A5-3124-458B-ACAB-98E57DC7C62AQ38251207-0A7FAB7B-4849-4CF1-9828-23224D0E5948Q38288242-7F6569EB-822D-4701-9B46-794F9D11E680
P2860
Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Effects of an angiotensin-conv ...... randomized, controlled study.
@en
Effects of an angiotensin-conv ...... randomized, controlled study.
@nl
type
label
Effects of an angiotensin-conv ...... randomized, controlled study.
@en
Effects of an angiotensin-conv ...... randomized, controlled study.
@nl
prefLabel
Effects of an angiotensin-conv ...... randomized, controlled study.
@en
Effects of an angiotensin-conv ...... randomized, controlled study.
@nl
P2093
P1476
Effects of an angiotensin-conv ...... randomized, controlled study.
@en
P2093
Cheuk-Chun Szeto
Chi-Bon Leung
Kai-Ming Chow
Philip Kam-Tao Li
Teresa Yuk-Hwa Wong
P304
P356
10.7326/0003-4819-139-2-200307150-00010
P407
P577
2003-07-01T00:00:00Z